|
Prescription and Over-the-Counter Drug Product List - 21st Edition
Cumulative Supplement Number 5: January-May 2001
ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE > ADD > ALMOTRIPTAN MALATE
CAPSULE; ORAL > ADD > TABLET; ORAL
ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE > ADD > AXERT
> DLT > + MIKART 150MG;180MG;15MG N81095 001 > ADD > PHARMACIA AND UPJOHN EQ 6.25MG BASE N21001 001
> DLT > OCT 26, 1990 > ADD > MAY 07, 2001
> DLT > + 150MG;180MG;60MG N81097 001 > ADD > + EQ 12.5MG BASE N21001 002
> DLT > OCT 26, 1990 > ADD > MAY 07, 2001
> ADD > @ 150MG;180MG;15MG N81095 001
> ADD > OCT 26, 1990
> ADD > @ 150MG;180MG;60MG N81097 001 AMIKACIN SULFATE
> ADD > OCT 26, 1990
INJECTABLE; INJECTION
AMIKACIN SULFATE
ACETAMINOPHEN; CODEINE PHOSPHATE > DLT > AP ABBOTT EQ 250MG BASE/ML N64099 001
> DLT > JUN 20, 1995
TABLET; ORAL > ADD > @ EQ 250MG BASE/ML N64099 001
ACETAMINOPHEN AND CODEINE PHOSPHATE > ADD > JUN 20, 1995
> ADD > AA MALLINCKRODT 300MG;15MG N40419 001
> ADD > MAY 31, 2001
> ADD > AA 300MG;30MG N40419 002 AMINOCAPROIC ACID
> ADD > MAY 31, 2001
> ADD > AA 300MG;60MG N40419 003 TABLET; ORAL
> ADD > MAY 31, 2001 AMICAR
> ADD > AB + IMMUNEX 500MG N15197 001
> DLT > + 500MG N15197 001
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE > ADD > AMINOCAPROIC
> ADD > AB MIKART 500MG N75602 001
TABLET; ORAL > ADD > MAY 24, 2001
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
> DLT > AB HALSEY 325MG;50MG N70115 001
> DLT > JUN 12, 1985 AMOXICILLIN
> DLT > AB 650MG;100MG N70116 001
> DLT > JUN 12, 1985 FOR SUSPENSION; ORAL
> ADD > @ 325MG;50MG N70115 001 TRIMOX
> ADD > JUN 12, 1985 > ADD > @ APOTHECON 125MG/5ML N61886 002
> ADD > @ 650MG;100MG N70116 001 > ADD > @ 50MG/ML N61886 001
> ADD > JUN 12, 1985 > ADD > @ 250MG/5ML N61886 003
POWDER FOR RECONSTITUTION; ORAL
ALLOPURINOL TRIMOX
> DLT > AB APOTHECON 125MG/5ML N61886 002
TABLET; ORAL > DLT > AB 50MG/ML N61886 001
ZYLOPRIM > DLT > AB 250MG/5ML N61886 003
> DLT > AB FARO PHARMS 100MG N16084 001
> DLT > AB + 300MG N16084 002
> ADD > AB PROMETHEUS LABS 100MG N16084 001
> ADD > AB + 300MG N16084 002
AMPHOTERICIN B AMPICILLIN SODIUM
INJECTABLE; INJECTION INJECTABLE; INJECTION
AMPHOTERICIN B OMNIPEN-N
> DLT > AP ABBOTT 50MG/VIAL N64141 001 > DLT > AP WYETH AYERST EQ 250MG BASE/VIAL N62718 002
> DLT > DEC 23, 1996 > DLT DEC 16, 1986
> ADD > @ 50MG/VIAL N64141 001 > DLT > AP EQ 500MG BASE/VIAL N62718 003
> ADD > DEC 23, 1996 > DLT > DEC 16, 1986
> DLT > AP EQ 1GM BASE/VIAL N62718 004
> DLT > DEC 16, 1986
AMPICILLIN SODIUM > DLT > AP EQ 2GM BASE/VIAL N62718 005
> DLT > DEC 16, 1986
INJECTABLE; INJECTION > ADD > @ EQ 125MG BASE/VIAL N62718 001
AMPICILLIN SODIUM > ADD > DEC 16, 1986
> DLT > AP ELKINS SINN EQ 125MG BASE/VIAL N62692 001 > ADD > @ EQ 250MG BASE/VIAL N62718 002
> DLT > JUN 24, 1986 > ADD > DEC 16, 1986
> DLT > AP EQ 250MG BASE/VIAL N62692 002 > ADD > @ EQ 500MG BASE/VIAL N62718 003
> DLT > JUN 24, 1986 > ADD > DEC 16, 1986
> DLT > AP EQ 500MG BASE/VIAL N62692 003 > ADD > @ EQ 1GM BASE/VIAL N62718 004
> DLT > JUN 24, 1986 > ADD > DEC 16, 1986
> DLT > AP EQ 1GM BASE/VIAL N62692 004 > ADD > @ EQ 2GM BASE/VIAL N62718 005
> DLT > JUN 24, 1986 > ADD > DEC 16, 1986
> DLT > AP EQ 2GM BASE/VIAL N62692 005 TOTACILLIN-N
> DLT > JUN 24, 1986 > DLT > @ SMITHKLINE BEECHAM EQ 2GM BASE/VIAL N62727 002
> DLT > AP EQ 10GM BASE/VIAL N62692 006 > DLT > DEC 19, 1986
> DLT > JUN 24, 1986 > ADD > @ EQ 2GM BASE/VIAL N62727 002
> ADD > @ EQ 125MG BASE/VIAL N62692 001 > ADD > DEC 19, 1986
> ADD > JUN 24, 1986
> ADD > @ EQ 250MG BASE/VIAL N62692 002
> ADD > JUN 24, 1986 AMPICILLIN/AMPICILLIN TRIHYDRATE
> ADD > @ EQ 500MG BASE/VIAL N62692 003
> ADD > JUN 24, 1986 CAPSULE; ORAL
> ADD > @ EQ 1GM BASE/VIAL N62692 004 AMPICILLIN TRIHYDRATE
> ADD > JUN 24, 1986 > DLT > AB BIOCHEMIE EQ 250MG BASE N64082 001
> ADD > @ EQ 2GM BASE/VIAL N62692 005 > DLT > AUG 29, 1995
> ADD > JUN 24, 1986 > DLT > AB EQ 500MG BASE N64082 002
> ADD > @ EQ 10GM BASE/VIAL N62692 006 > DLT > AUG 29, 1995
> ADD > JUN 24, 1986 > ADD > @ EQ 250MG BASE N64082 001
> DLT > AP HANFORD GC EQ 1GM BASE/VIAL N62772 001 > ADD > AUG 29, 1995
> DLT > APR 15, 1993 > ADD > @ EQ 500MG BASE N64082 002
> ADD > @ EQ 1GM BASE/VIAL N62772 001 > ADD > AUG 29, 1995
> ADD > APR 15, 1993
> DLT > AP IBI EQ 125MG BASE/VIAL N62797 001 FOR SUSPENSION; ORAL
> DLT > JUL 12, 1993 AMPICILLIN TRIHYDRATE
> ADD > @ EQ 125MG BASE/VIAL N62797 001 > ADD > @ MYLAN EQ 125MG BASE/5ML N61829 002
> ADD > JUL 12, 1993 > ADD > @ EQ 250MG BASE/5ML N61829 001
OMNIPEN-N
> DLT > AP WYETH AYERST EQ 125MG BASE/VIAL N62718 001 POWDER FOR RECONSTITUTION; ORAL
> DLT > DEC 16, 1986 AMPICILLIN TRIHYDRATE
> DLT > AB MYLAN EQ 125MG BASE/5ML N61829 002
AMPICILLIN/AMPICILLIN TRIHYDRATE ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
POWDER FOR RECONSTITUTION; ORAL TABLET; ORAL
AMPICILLIN TRIHYDRATE DIPHENOXYLATE HCL AND ATROPINE SULFATE
> DLT > AB MYLAN EQ 250MG BASE/5ML N61829 001 > DLT > AA R AND S PHARMA 0.025MG;2.5MG N85035 001
> ADD > @ 0.025MG;2.5MG N85035 001
DIPHENOXYLATE HCL W/ ATROPINE SULFATE
AMPICILLIN/AMPICILLIN TRIHYDRATE; PROBENECID > DLT > AA PVT FORM 0.025MG;2.5MG N85766 001
> ADD > @ 0.025MG;2.5MG N85766 001
> ADD > FOR SUSPENSION; ORAL
> ADD > PROBAMPACIN
> ADD > @ TEVA EQ 3.5GM BASE/BOT;1GM/BOT N61741 001 AURANOFIN
> DLT > POWDER FOR RECONSTITUTION; ORAL CAPSULE; ORAL
> DLT > PROBAMPACIN RIDAURA
> DLT > + TEVA EQ 3.5GM BASE/BOT;1GM/BOT N61741 001 > DLT > + CONNETICS 3MG N18689 001
> DLT > MAY 24, 1985
> ADD > + PROMETHEUS LABS 3MG N18689 001
ARDEPARIN SODIUM > ADD > MAY 24, 1985
> DLT > INJECTABLE; INJECTION
> DLT > NORMIFLO AZATHIOPRINE
> DLT > + WYETH AYERST 5,000 UNITS/0.5ML N20227 002
> DLT > MAY 23, 1997 TABLET; ORAL
> DLT > + 10,000 UNITS/0.5ML N20227 001 IMURAN
> DLT > MAY 23, 1997 > DLT > AB + FARO PHARMS 50MG N16324 001
> ADD > @ 5,000 UNITS/0.5ML N20227 002 > ADD > AB + PROMETHEUS LABS 50MG N16324 001
> ADD > MAY 23, 1997
> ADD > @ 10,000 UNITS/0.5ML N20227 001
> ADD > MAY 23, 1997 BACITRACIN ZINC
> DLT > POWDER; FOR RX COMPOUNDING
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE > DLT > ZIBA-RX
> DLT > PHARMA TEK 500,000 UNITS/BOT N61737 001
CAPSULE; ORAL > ADD > @ 500,000 UNITS/BOT N61737 001
> DLT > PROPOXYPHENE COMPOUND 65
> DLT > AA EON 389MG;32.4MG;65MG N80044 002
> DLT > SEP 16, 1983 BENZQUINAMIDE HYDROCHLORIDE
> ADD > @ 389MG;32.4MG;65MG N80044 002
> ADD > SEP 16, 1983 INJECTABLE; INJECTION
> DLT > PROPOXYPHENE COMPOUND-65 EMETE-CON
> DLT > AA GENEVA PHARMS 389MG;32.4MG;65MG N83101 002 > ADD > + PFIZER EQ 50MG BASE/VIAL N16820 001
> DLT > JUN 24, 1985 > DLT > + ROERIG EQ 50MG BASE/VIAL N16820 001
> ADD > @ 389MG;32.4MG;65MG N83101 002
> ADD > JUN 24, 1985
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE CEFADROXIL/CEFADROXIL HEMIHYDRATE
CREAM; TOPICAL TABLET; ORAL
> ADD > CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CEFADROXIL
> ADD > AB TARO EQ 0.05% BASE;1% N75673 001 > DLT > AB ZENITH GOLDLINE EQ 1GM BASE N62774 001
> ADD > MAY 29, 2001 > DLT > APR 08, 1987
LOTRISONE > ADD > @ EQ 1GM BASE N62774 001
> ADD > AB + SCHERING EQ 0.05% BASE;1% N18827 001 > ADD > APR 08, 1987
> ADD > JUL 10, 1984
> DLT > + EQ 0.05% BASE;1% N18827 001
> DLT > JUL 10, 1984 CEFAMANDOLE NAFATE
INJECTABLE; INJECTION
BUTABARBITAL SODIUM MANDOL
> DLT > LILLY EQ 1GM BASE/VIAL N62560 001
TABLET; ORAL > DLT > SEP 10, 1985
BUTISOL SODIUM > DLT > EQ 2GM BASE/VIAL N62560 002
> DLT > AA + WALLACE LABS 15MG N00793 002 > DLT > SEP 10, 1985
> ADD > + 15MG N00793 002 > ADD > @ EQ 1GM BASE/VIAL N62560 001
SODIUM BUTABARBITAL > ADD > SEP 10, 1985
> DLT > AA LANNETT 15MG N85849 001 > ADD > @ EQ 2GM BASE/VIAL N62560 002
> DLT > AA 30MG N85866 001 > ADD > SEP 10, 1985
> ADD > @ 15MG N85849 001
> ADD > @ 30MG N85866 001
CEFAZOLIN SODIUM
CEFACLOR INJECTABLE; INJECTION
KEFZOL
FOR SUSPENSION; ORAL > DLT > AP LILLY EQ 500MG BASE/VIAL N62557 001
CEFACLOR > DLT > SEP 10, 1985
> ADD > @ ZENITH GOLDLINE EQ 125MG BASE/5ML N64087 001 > DLT > AP EQ 1GM BASE/VIAL N62557 002
> ADD > APR 28, 1995 > DLT > SEP 10, 1985
> ADD > @ EQ 187MG BASE/5ML N64086 001 > ADD > @ EQ 500MG BASE/VIAL N62557 001
> ADD > APR 28, 1995 > ADD > SEP 10, 1985
> ADD > @ EQ 250MG BASE/5ML N64085 001 > ADD > @ EQ 1GM BASE/VIAL N62557 002
> ADD > APR 28, 1995 > ADD > SEP 10, 1985
POWDER FOR RECONSTITUTION; ORAL
CEFACLOR CEFOPERAZONE SODIUM
> DLT > AB ZENITH GOLDLINE EQ 125MG BASE/5ML N64087 001
> DLT > APR 28, 1995 INJECTABLE; INJECTION
> DLT > AB EQ 187MG BASE/5ML N64086 001 CEFOBID
> DLT > APR 28, 1995 > DLT > PFIZER EQ 1GM BASE/VIAL N63333 001
> DLT > AB EQ 250MG BASE/5ML N64085 001 > DLT > MAR 31, 1995
> DLT > APR 28, 1995 > DLT > EQ 2GM BASE/VIAL N63333 002
> DLT > MAR 31, 1995
> ADD > @ EQ 1GM BASE/VIAL N63333 001
> ADD > MAR 31, 1995
5
CEFOPERAZONE SODIUM CEFUROXIME SODIUM
INJECTABLE; INJECTION INJECTABLE; IM - IV
CEFOBID CEFUROXIME
> ADD > @ PFIZER EQ 2GM BASE/VIAL N63333 002 > ADD > AB AM PHARM PARTNERS EQ 750MG BASE/VIAL N65001 001
> ADD > MAR 31, 1995 > ADD > MAY 30, 2001
CEFUROXIME SODIUM
> ADD > AB HANFORD GC EQ 750MG BASE/VIAL N64125 001
CEFORANIDE > ADD > MAY 30, 1997
KEFUROX
INJECTABLE; INJECTION > ADD > AB LILLY EQ 750MG BASE/VIAL N62591 001
PRECEF > ADD > JAN 10, 1986
> DLT > APOTHECON 500MG/VIAL N62579 001 ZINACEF
> DLT > NOV 26, 1984 > ADD > AB + GLAXO WELLCOME EQ 750MG BASE/VIAL N50558 002
> DLT > 1GM/VIAL N62579 002 > ADD > OCT 19, 1983
> DLT > NOV 26, 1984
> DLT > 2GM/VIAL N62579 003 INJECTABLE; IM-IV
> DLT > NOV 26, 1984 CEFUROXIME
> DLT > 10GM/VIAL N62579 004 > ADD > AB TEVA EQ 750MG BASE/VIAL N64192 002
> DLT > NOV 26, 1984 > ADD > APR 16, 1998
> DLT > 20GM/VIAL N62579 005
> DLT > NOV 26, 1984 INJECTABLE; INJECTION
> ADD > @ 500MG/VIAL N62579 001 CEFUROXIME
> ADD > NOV 26, 1984 > ADD > AP AM PHARM PARTNERS EQ 1.5GM BASE/VIAL N65001 002
> ADD > @ 1GM/VIAL N62579 002 > ADD > MAY 30, 2001
> ADD > NOV 26, 1984 > DLT > AB TEVA EQ 750MG BASE/VIAL N64192 002
> ADD > @ 2GM/VIAL N62579 003 > DLT > APR 16, 1998
> ADD > NOV 26, 1984 CEFUROXIME SODIUM
> ADD > @ 10GM/VIAL N62579 004 > DLT > AB HANFORD GC EQ 750MG BASE/VIAL N64125 001
> ADD > NOV 26, 1984 > DLT > MAY 30, 1997
> ADD > @ 20GM/VIAL N62579 005 KEFUROX
> ADD > NOV 26, 1984 > DLT > AB LILLY EQ 750MG BASE/VIAL N62591 001
> DLT > JAN 10, 1986
> DLT > KEFUROX IN PLASTIC CONTAINER
CEFTAZIDIME > DLT > AP LILLY EQ 750MG BASE/VIAL N62590 001
> DLT > JAN 10, 1986
INJECTABLE; INJECTION > DLT > AP EQ 1.5GM BASE/VIAL N62590 002
> DLT > TAZIDIME IN PLASTIC CONTAINER > DLT > JAN 10, 1986
> DLT > AP LILLY 1GM/VIAL N62739 001 > ADD > @ EQ 1.5GM BASE/VIAL N62590 002
> DLT > JUL 10, 1986 > ADD > JAN 10, 1986
> DLT > AP 2GM/VIAL N62739 002 ZINACEF
> DLT > JUL 10, 1986 > DLT > AB + GLAXO WELLCOME EQ 750MG BASE/VIAL N50558 002
> ADD > @ 1GM/VIAL N62739 001 > DLT > OCT 19, 1983
> ADD > JUL 10, 1986
> ADD > @ 2GM/VIAL N62739 002 INJECTABLE; INTRAVENOUS
> ADD > JUL 10, 1986 > ADD > KEFUROX IN PLASTIC CONTAINER
> ADD > @ LILLY EQ 750MG BASE/VIAL N62590 001
> ADD > JAN 10, 1986
CEPHALEXIN CHLORDIAZEPOXIDE HYDROCHLORIDE
CAPSULE; ORAL CAPSULE; ORAL
CEPHALEXIN CHLORDIAZEPOXIDE HCL
> DLT > AB TEVA EQ 500MG BASE N62823 001 > DLT > AB GENEVA PHARMS 25MG N84679 002
> DLT > FEB 05, 1988 > ADD > @ 25MG N84679 002
> ADD > @ EQ 500MG BASE N62823 001 > DLT > AB ROSEMONT 5MG N84644 001
> ADD > FEB 05, 1988 > ADD > @ 5MG N84644 001
FOR SUSPENSION; ORAL
CEPHALEXIN CHLOROTHIAZIDE
> ADD > @ BARR EQ 125MG BASE/5ML N62778 001
> ADD > AUG 06, 1987 TABLET; ORAL
CHLOROTHIAZIDE
POWDER FOR RECONSTITUTION; ORAL > ADD > @ ABC HOLDING 250MG N85569 001
CEPHALEXIN > DLT > AB CAMALL 250MG N85569 001
> DLT > AB BARR EQ 125MG BASE/5ML N62778 001 > DLT > AB DANBURY PHARMA 250MG N85173 001
> DLT > AUG 06, 1987 > ADD > @ 250MG N85173 001
CHLORAMPHENICOL CHLORPHENIRAMINE MALEATE
CAPSULE; ORAL TABLET; ORAL
> DLT > CHLORAMPHENICOL CHLORPHENIRAMINE MALEATE
> DLT > AB ZENITH GOLDLINE 250MG N62247 001 > DLT > AA + GENEVA PHARMS 4MG N80961 001
> ADD > @ 250MG N62247 001 > ADD > @ 4MG N80961 001
> DLT > CHLOROMYCETIN > DLT > AA ICN 4MG N80598 001
> DLT > AB + PARKEDALE 250MG N60591 002 > ADD > AA + 4MG N80598 001
> DLT > 50MG N60591 001
> DLT > 100MG N60591 003
> ADD > @ 50MG N60591 001 CHLORPROMAZINE HYDROCHLORIDE
> ADD > @ 100MG N60591 003
> ADD > @ 250MG N60591 002 INJECTABLE; INJECTION
MYCHEL CHLORPROMAZINE HCL
> DLT > AB ARMENPHARM 250MG N60851 001 > DLT > AP STERIS 25MG/ML N80365 001
> ADD > + 250MG N60851 001 > ADD > @ 25MG/ML N80365 001
SOLUTION/DROPS; OPHTHALMIC
> DLT > CHLORAMPHENICOL CHLORZOXAZONE
> DLT > AT ALCON 0.5% N62628 001
> DLT > SEP 25, 1985 TABLET; ORAL
> ADD > @ 0.5% N62628 001 CHLORZOXAZONE
> ADD > SEP 25, 1985 > DLT > AA DANBURY PHARMA 500MG N81019 001
CHLOROPTIC > DLT > JUL 29, 1991
> DLT > AT + ALLERGAN 0.5% N50091 001 > ADD > @ 500MG N81019 001
> ADD > + 0.5% N50091 001 > ADD > JUL 29, 1991
CLINDAMYCIN PHOSPHATE DEXAMETHASONE
INJECTABLE; INJECTION TABLET; ORAL
CLINDAMYCIN PHOSPHATE DEXAMETHASONE
> DLT > AP ABBOTT EQ 150MG BASE/ML N62943 001 > DLT > BP DANBURY PHARMA 0.75MG N80968 001
> DLT > SEP 29, 1988 > ADD > @ 0.75MG N80968 001
> ADD > @ EQ 150MG BASE/ML N62943 001
> ADD > SEP 29, 1988
> DLT > AP ELKINS SINN EQ 150MG BASE/ML N62806 001 DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
> DLT > OCT 15, 1987
> DLT > AP EQ 150MG BASE/ML N62953 001 OINTMENT; OPHTHALMIC
> DLT > APR 21, 1988 > DLT > DEXACIDIN
> ADD > @ EQ 150MG BASE/ML N62806 001 > DLT > AT CIBA 0.1%;EQ 3.5MG BASE/GM;
> ADD > OCT 15, 1987 > DLT > 10,000 UNITS/GM N62566 001
> ADD > @ EQ 150MG BASE/ML N62953 001 > DLT > FEB 22, 1985
> ADD > APR 21, 1988 > ADD > @ NOVARTIS 0.1%;EQ 3.5MG BASE/GM;
> DLT > AP LEDERLE EQ 150MG BASE/ML N63068 001 > ADD > 10,000 UNITS/GM N62566 001
> DLT > AUG 28, 1989 > ADD > FEB 22, 1985
> ADD > @ EQ 150MG BASE/ML N63068 001
> ADD > AUG 28, 1989
DEXAMETHASONE SODIUM PHOSPHATE
SOLUTION; TOPICAL
CLINDAMYCIN PHOSPHATE INJECTABLE; INJECTION
> DLT > AT COPLEY PHARM EQ 1% BASE N62944 001 DEXAMETHASONE SODIUM PHOSPHATE
> DLT > JAN 11, 1989 > DLT > AP GENSIA SICOR PHARMS EQ 4MG PHOSPHATE/ML N81125 001
> ADD > @ EQ 1% BASE N62944 001 > DLT > AUG 31, 1990
> ADD > JAN 11, 1989 > ADD > @ EQ 4MG PHOSPHATE/ML N81125 001
> DLT > AT TEVA EQ 1% BASE N62930 001 > ADD > AUG 31, 1990
> DLT > JUN 28, 1989
> ADD > @ EQ 1% BASE N62930 001 OINTMENT; OPHTHALMIC
> ADD > JUN 28, 1989 > DLT > DECADRON
> DLT > AT + MERCK EQ 0.05% PHOSPHATE N11977 001
> ADD > @ EQ 0.05% PHOSPHATE N11977 001
CYCLACILLIN MAXIDEX
> DLT > AT ALCON EQ 0.05% PHOSPHATE N83342 001
> DLT > TABLET; ORAL > ADD > + EQ 0.05% PHOSPHATE N83342 001
> DLT > CYCLACILLIN
> DLT > TEVA 250MG N62895 001
> DLT > AUG 04, 1988 DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE
> DLT > + 500MG N62895 002
> DLT > AUG 04, 1988 SOLUTION/DROPS; OPHTHALMIC
> ADD > @ 250MG N62895 001 NEODECADRON
> ADD > AUG 04, 1988 > DLT > AT + MERCK EQ 0.1% PHOSPHATE;
> ADD > @ 500MG N62895 002 > DLT > EQ 3.5MG BASE/ML N50322 001
> ADD > AUG 04, 1988 > ADD > + EQ 0.1% PHOSPHATE;
> ADD > EQ 3.5MG BASE/ML N50322 001
> DLT > NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
> DLT > AT ALCON UNIVERSAL EQ 0.1% PHOSPHATE;
> DLT > EQ 3.5MG BASE/ML N62714 001
> DLT > JUL 21, 1986
DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE DOXYCYCLINE HYCLATE
SOLUTION/DROPS; OPHTHALMIC INJECTABLE; INJECTION
> ADD > NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE > DLT > DOXYCYCLINE HYCLATE
> ADD > @ ALCON UNIVERSAL EQ 0.1% PHOSPHATE; > DLT > AP LEDERLE EQ 200MG BASE/VIAL N62992 002
> ADD > EQ 3.5MG BASE/ML N62714 001 > DLT FEB 16, 1989
> ADD > JUL 21, 1986 > ADD > @ EQ 100MG BASE/VIAL N62992 001
> ADD > FEB 16, 1989
> ADD > @ EQ 200MG BASE/VIAL N62992 002
DICYCLOMINE HYDROCHLORIDE > ADD > FEB 16, 1989
CAPSULE; ORAL TABLET; ORAL
DICYCLOMINE HCL > DLT > DOXY-LEMMON
> DLT > AB HALSEY 10MG N84505 001 > DLT > AB TEVA EQ 100MG BASE N62581 001
> DLT > OCT 21, 1986 > DLT > MAR 15, 1985
> ADD > @ 10MG N84505 001 > ADD > @ EQ 100MG BASE N62581 001
> ADD > OCT 21, 1986 > ADD > MAR 15, 1985
DIPHENHYDRAMINE HYDROCHLORIDE > ADD > DROSPIRENONE; ETHINYL ESTRADIOL
CAPSULE; ORAL > ADD > TABLET; ORAL-28
DIPHENHYDRAMINE HCL > ADD > YASMIN
> DLT > AA CHELSEA LABS 50MG N85083 001 > ADD > + BERLEX LABS 3MG;0.03MG N21098 001
> ADD > @ 50MG N85083 001 > ADD > MAY 11, 2001
DOXYCYCLINE HYCLATE ERYTHROMYCIN
CAPSULE, COATED PELLETS; ORAL SOLUTION; TOPICAL
> DLT > DOXYCYCLINE HYCLATE ERYTHROMYCIN
> DLT > AB SIDMAK LABS NJ EQ 100MG BASE N63187 001 > ADD > AT CLAY PARK 2% N63038 001
> DLT > JUN 30, 1992 > ADD > JAN 11, 1991
> ADD > @ EQ 100MG BASE N63187 001 > DLT > 2% N63038 001
> ADD > JUN 30, 1992 > DLT > JAN 11, 1991
INJECTABLE; INJECTION TABLET, DELAYED RELEASE; ORAL
> DLT > DOXYCYCLINE > DLT > ILOTYCIN
> DLT > AP BEDFORD EQ 100MG BASE/VIAL N62569 001 > DLT > AB DISTA 250MG N61910 001
> DLT > MAR 09, 1988 > ADD > @ 250MG N61910 001
> DLT > AP EQ 200MG BASE/VIAL N62569 002
> DLT > MAR 09, 1988
> ADD > @ EQ 100MG BASE/VIAL N62569 001 ERYTHROMYCIN ESTOLATE
> ADD > MAR 09, 1988
> ADD > @ EQ 200MG BASE/VIAL N62569 002 CAPSULE; ORAL
> ADD > MAR 09, 1988 > DLT > ERYTHROMYCIN ESTOLATE
> DLT > DOXYCYCLINE HYCLATE > DLT > AB BARR EQ 250MG BASE N62162 002
> DLT > AP LEDERLE EQ 100MG BASE/VIAL N62992 001 > ADD > + EQ 250MG BASE N62162 002
> DLT > FEB 16, 1989 > DLT > ILOSONE
> DLT > AB + LILLY EQ 250MG BASE N61897 002
ERYTHROMYCIN ESTOLATE FAMOTIDINE
CAPSULE; ORAL INJECTABLE; INJECTION
> DLT > ILOSONE FAMOTIDINE
> DLT > LILLY EQ 125MG BASE N61897 001 > DLT > AP APOTHECON 10MG/ML N75707 001
> ADD > @ EQ 125MG BASE N61897 001 > DLT > APR 16, 2001
> ADD > @ EQ 250MG BASE N61897 002 > ADD > @ APOTHECON 10MG/ML N75707 001
> ADD > APR 16, 2001
> ADD > FOR SUSPENSION; ORAL FAMOTIDINE PRESERVATIVE FREE
> ADD > ILOSONE > DLT > AP APOTHECON 10MG/ML N75708 001
> ADD > @ DISTA EQ 125MG BASE/5ML N61893 001 > DLT > APR 16, 2001
> ADD > @ APOTHECON 10MG/ML N75708 001
> DLT > POWDER FOR RECONSTITUTION; ORAL > ADD > APR 16, 2001
> DLT > ILOSONE > ADD > FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
> DLT > + DISTA EQ 125MG BASE/5ML N61893 001 > ADD > AP BAXTER HLTHCARE 0.4MG/ML N75591 001
> ADD > MAY 10, 2001
> DLT > TABLET, CHEWABLE; ORAL PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
> DLT > ILOSONE > ADD > AP + MERCK 0.4MG/ML N20249 001
> DLT > DISTA EQ 125MG BASE N61895 001 > ADD > FEB 18, 1994
> DLT > + EQ 250MG BASE N61895 002 > DLT > + 0.4MG/ML N20249 001
> ADD > @ EQ 125MG BASE N61895 001 > DLT > FEB 18, 1994
> ADD > @ EQ 250MG BASE N61895 002
TABLET; ORAL
FAMOTIDINE
ERYTHROMYCIN ETHYLSUCCINATE > ADD > AB INVAMED 20MG N75607 001
> ADD > MAY 10, 2001
TABLET; ORAL > ADD > AB 40MG N75607 002
ERYTHROMYCIN ETHYLSUCCINATE > ADD > MAY 10, 2001
> DLT > AB BARR EQ 400MG BASE N62256 001
> ADD > @ EQ 400MG BASE N62256 001
FENTANYL
ERYTHROMYCIN STEARATE FILM, EXTENDED RELEASE; TRANSDERMAL
DURAGESIC
TABLET; ORAL > DLT > + ALZA 1.2MG/24HR N19813 003
ERYTHROMYCIN STEARATE > DLT > AUG 07, 1990
> DLT > AB BARR EQ 500MG BASE N63179 001 > DLT > + 1.8MG/24HR N19813 002
> DLT > MAY 15, 1990 > DLT > AUG 07, 1990
> ADD > @ EQ 500MG BASE N63179 001 > DLT > + 2.4MG/24HR N19813 001
> ADD > MAY 15, 1990 > DLT > AUG 07, 1990
> DLT > AB ZENITH GOLDLINE EQ 250MG BASE N61461 001 > ADD > 1.2MG/24HR N19813 003
> DLT > AB EQ 500MG BASE N61461 002 > ADD > AUG 07, 1990
> ADD > @ EQ 250MG BASE N61461 001 > ADD > 1.8MG/24HR N19813 002
> ADD > @ EQ 500MG BASE N61461 002 > ADD > AUG 07, 1990
> ADD > 2.4MG/24HR N19813 001
> ADD > AUG 07, 1990
FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE GENTAMICIN SULFATE
> DLT > CREAM; TOPICAL OINTMENT; OPHTHALMIC
> DLT > NEO-SYNALAR > ADD > GENTACIDIN
> DLT > + MEDICIS 0.025%;EQ 3.5MG BASE/GM N60700 001 > ADD > @ NOVARTIS EQ 0.3% BASE N62501 001
> ADD > @ 0.025%;EQ 3.5MG BASE/GM N60700 001 > ADD > JUL 26, 1984
OINTMENT; TOPICAL
FLUOROURACIL GENTAMICIN SULFATE
> DLT > AT BAUSCH AND LOMB EQ 0.1% BASE N64054 001
CREAM; TOPICAL > DLT > APR 29, 1994
CARAC > ADD > @ EQ 0.1% BASE N64054 001
> ADD > + DERMIK LABS 0.5% N20985 001 > ADD > APR 29, 1994
> ADD > OCT 27, 2000
FLUOROURACIL
> DLT > + DERMIK LABS 0.5% N20985 001 GLYCOPYRROLATE
> DLT > OCT 27, 2000
INJECTABLE; INJECTION
GLYCOPYRROLATE
FLUVOXAMINE MALEATE > DLT > AP GENSIA SICOR PHARMS 0.2MG/ML N81169 001
> DLT > SEP 10, 1991
TABLET; ORAL > ADD > @ 0.2MG/ML N81169 001
FLUVOXAMINE MALEATE > ADD > SEP 10, 1991
> ADD > AB TORPHARM 25MG N75902 001
> ADD > MAY 07, 2001
> ADD > AB 50MG N75902 002 GRISEOFULVIN, ULTRAMICROCRYSTALLINE
> ADD > MAY 07, 2001
> ADD > AB 100MG N75902 003 TABLET; ORAL
> ADD > MAY 07, 2001 > DLT > ULTRAGRIS-165
> DLT > AB SIDMAK LABS NJ 165MG N62645 001
> DLT > JUN 30, 1992
GENTAMICIN SULFATE > ADD > @ 165MG N62645 001
> ADD > JUN 30, 1992
CREAM; TOPICAL > DLT > ULTRAGRIS-330
GENTAMICIN SULFATE > DLT > AB SIDMAK LABS NJ 330MG N62646 001
> DLT > AT BAUSCH AND LOMB EQ 0.1% BASE N64056 001 > DLT > JUN 30, 1992
> DLT > APR 29, 1994 > ADD > @ 330MG N62646 001
> ADD > @ EQ 0.1% BASE N64056 001 > ADD > JUN 30, 1992
> ADD > APR 29, 1994
INJECTABLE; INJECTION HEPARIN SODIUM
GENTAMICIN SULFATE
> DLT > AP GENSIA SICOR PHARMS EQ 10MG BASE/ML N63149 001 INJECTABLE; INJECTION
> DLT > NOV 21, 1991 HEPARIN SODIUM
> ADD > @ EQ 10MG BASE/ML N63149 001 > DLT > AP ABBOTT 10,000 UNITS/ML N40095 001
> ADD > NOV 21, 1991 > DLT > JUL 26, 1996
> ADD > @ 10,000 UNITS/ML N40095 001
OINTMENT; OPHTHALMIC > ADD > JUL 26, 1996
> DLT > GENTACIDIN
> DLT > AT CIBA EQ 0.3% BASE N62501 001
> DLT > JUL 26, 1984
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE HYDROCORTISONE
TABLET; ORAL LOTION; TOPICAL
> DLT > RESERPINE, HYDRALAZINE HCL AND HYDROCHLOROTHIAZIDE HYDROCORTISONE
> DLT > BP DANBURY PHARMA 25MG;15MG;0.1MG N85549 001 > DLT > AT MERICON 1% N85282 002
> ADD > @ 25MG;15MG;0.1MG N85549 001 > DLT FEB 26, 1987
> ADD > @ 0.5% N85282 001
> ADD > @ 1% N85282 002
HYDROCHLOROTHIAZIDE > ADD > FEB 26, 1987
TABLET; ORAL TABLET; ORAL
HYDROCHLOROTHIAZIDE HYDROCORTISONE
> DLT > AB DANBURY PHARMA 50MG N83232 001 > DLT > BP LANNETT 20MG N85070 001
> ADD > @ 50MG N83232 001 > ADD > @ 20MG N85070 001
> DLT > AB HALSEY 25MG N83972 001
> DLT > AB 50MG N83972 002
> ADD > @ 25MG N83972 001 HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
> ADD > @ 50MG N83972 002
> DLT > AB IMPAX LABS 25MG N84029 001 SUSPENSION/DROPS; OPHTHALMIC
> DLT > AB 50MG N83607 002 CORTISPORIN
> ADD > @ 25MG N84029 001 > DLT > AT + MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;
> ADD > @ 50MG N83607 002 > DLT > 10,000 UNITS/ML N50169 001
> DLT > AB PHARMERAL 25MG N84325 001 > ADD > + 1%;EQ 3.5MG BASE/ML;
> DLT > AB 50MG N84324 001 > ADD > 10,000 UNITS/ML N50169 001
> ADD > @ 25MG N84325 001 > DLT > NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
> ADD > @ 50MG N84324 001 > DLT > AT ALCON UNIVERSAL 1%;EQ 3.5MG BASE/ML;
> DLT > AB WEST WARD 50MG N84878 001 > DLT > 10,000 UNITS/ML N62874 001
> ADD > @ 50MG N84878 001 > DLT > MAY 11, 1988
> ADD > @ 1%;EQ 3.5MG BASE/ML;
> ADD > 10,000 UNITS/ML N62874 001
HYDROCHLOROTHIAZIDE; RESERPINE > ADD > MAY 11, 1988
TABLET; ORAL
> ADD > HYDRO-RESERP HYDROXYZINE HYDROCHLORIDE
> ADD > @ ABC HOLDING 50MG;0.125MG N84714 002
> ADD > JUN 29, 1982 INJECTABLE; INJECTION
> DLT > BP CAMALL 50MG;0.125MG N84714 002 HYDROXYZINE HCL
> DLT > JUN 29, 1982 > DLT > AP STERIS 25MG/ML N85778 001
> DLT > HYDROCHLOROTHIAZIDE W/ RESERPINE > ADD > @ 25MG/ML N85778 001
> DLT > BP DANBURY PHARMA 25MG;0.125MG N84466 001
> DLT > BP 50MG;0.125MG N84467 001
> ADD > @ 25MG;0.125MG N84466 001 HYDROXYZINE PAMOATE
> ADD > @ 50MG;0.125MG N84467 001
CAPSULE; ORAL
HYDROXYZINE PAMOATE
HYDROCORTISONE > DLT > AB GENEVA PHARMS EQ 50MG HCL N81128 001
> DLT > JUN 28, 1991
LOTION; TOPICAL > DLT > AB EQ 100MG HCL N81129 001
HYDROCORTISONE > DLT > JUN 28, 1991
> DLT > AT MERICON 0.5% N85282 001
HYDROXYZINE PAMOATE KANAMYCIN SULFATE
CAPSULE; ORAL INJECTABLE; INJECTION
HYDROXYZINE PAMOATE > ADD > KANAMYCIN SULFATE
> ADD > @ GENEVA PHARMS EQ 50MG HCL N81128 001 > ADD > @ LOCH EQ 500MG BASE/2ML N63022 001
> ADD > JUN 28, 1991 > ADD > JUL 31, 1992
> ADD > @ EQ 100MG HCL N81129 001 > DLT > AP STERIS EQ 1GM BASE/3ML N62520 003
> ADD > JUN 28, 1991 > DLT > MAY 09, 1985
> ADD > @ EQ 1GM BASE/3ML N62520 003
> ADD > MAY 09, 1985
> ADD > IMATINIB MESYLATE KANTREX
> DLT > AP + APOTHECON EQ 75MG BASE/2ML N61901 003
> ADD > CAPSULE; ORAL > DLT > AP + EQ 500MG BASE/2ML N61901 001
> ADD > GLEEVEC > DLT > AP + EQ 1GM BASE/3ML N61901 002
> ADD > NOVARTIS 50MG N21335 001 > ADD > + EQ 75MG BASE/2ML N61901 003
> ADD > MAY 10, 2001 > ADD > + EQ 500MG BASE/2ML N61901 001
> ADD > + 100MG N21335 002 > ADD > + EQ 1GM BASE/3ML N61901 002
> ADD > MAY 10, 2001
KETOROLAC TROMETHAMINE
ISONIAZID
INJECTABLE; INJECTION
SYRUP; ORAL KETOROLAC TROMETHAMINE
ISONIAZID > DLT > AP APOTHECON 15MG/ML N75348 001
> DLT > AA + CAROLINA MEDCL 50MG/5ML N88235 001 > DLT > NOV 28, 2000
> DLT > NOV 10, 1983 > DLT > AP 30MG/ML N75348 002
> ADD > + 50MG/5ML N88235 001 > DLT > NOV 28, 2000
> ADD > NOV 10, 1983 > ADD > @ 15MG/ML N75348 001
> DLT > AA MIKART 50MG/5ML N81118 001 > ADD > NOV 28, 2000
> DLT > JUL 21, 1997 > ADD > @ 30MG/ML N75348 002
> ADD > @ 50MG/5ML N81118 001 > ADD > NOV 28, 2000
> ADD > JUL 21, 1997
TABLET; ORAL LABETALOL HYDROCHLORIDE
ISONIAZID
> DLT > AA HALSEY 100MG N80136 001 INJECTABLE; INJECTION
> ADD > @ 100MG N80136 001 LABETALOL HCL
> DLT > AP APOTHECON 5MG/ML N75355 001
> DLT > NOV 29, 1999
KANAMYCIN SULFATE > ADD > @ 5MG/ML N75355 001
> ADD > NOV 29, 1999
INJECTABLE; INJECTION TRANDATE
> DLT > KANAMYCIN SULFATE > DLT > AP + FARO PHARMS 5MG/ML N19425 001
> DLT > AP LOCH EQ 75MG BASE/2ML N63021 001 > DLT > DEC 31, 1985
> DLT > JUL 31, 1992 > ADD > AP + PROMETHEUS LABS 5MG/ML N19425 001
> DLT > AP EQ 500MG BASE/2ML N63022 001 > ADD > DEC 31, 1985
> DLT > JUL 31, 1992
> ADD > @ EQ 75MG BASE/2ML N63021 001
> ADD > JUL 31, 1992
LANSOPRAZOLE LEVOTHYROXINE SODIUM
> ADD > FOR SUSPENSION, EXTENDED RELEASE; ORAL TABLET; ORAL
> ADD > PREVACID UNITHROID
> ADD > TAP PHARM 15MG/PACKET N21281 001 > ADD BX STEVENS J 0.05MG N21210 002
> ADD > MAY 03, 2001 > ADD > AUG 21, 2000
> ADD > + 30MG/PACKET N21281 002 > ADD > BX 0.075MG N21210 003
> ADD > MAY 03, 2001 > ADD > AUG 21, 2000
> ADD > BX 0.088MG N21210 004
> ADD > AUG 21, 2000
LEVODOPA > ADD > BX 0.1MG N21210 005
> ADD > AUG 21, 2000
> DLT > CAPSULE; ORAL > ADD > BX 0.112MG N21210 006
> DLT > DOPAR > ADD > AUG 21, 2000
> DLT > + ROBERTS LABS 250MG N16913 001 > ADD > BX 0.125MG N21210 007
> ADD > @ SHIRE LABS 250MG N16913 001 > ADD > AUG 21, 2000
> ADD > BX 0.15MG N21210 008
> ADD > AUG 21, 2000
LEVOTHYROXINE SODIUM > ADD > BX 0.175MG N21210 009
> ADD > AUG 21, 2000
TABLET; ORAL > ADD > BX 0.2MG N21210 010
> ADD > LEVOXYL > ADD > AUG 21, 2000
> ADD > BX + JONES PHARMA 0.025MG N21301 001 > ADD > BX + 0.3MG N21210 011
> ADD > MAY 25, 2001 > ADD > AUG 21, 2000
> ADD > BX 0.05MG N21301 002 > DLT > 0.025MG N21210 001
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.075MG N21301 003 > DLT > 0.05MG N21210 002
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.088MG N21301 004 > DLT > 0.075MG N21210 003
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.1MG N21301 005 > DLT > 0.088MG N21210 004
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.112MG N21301 006 > DLT > 0.1MG N21210 005
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.125MG N21301 007 > DLT > 0.112MG N21210 006
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.137MG N21301 008 > DLT > 0.125MG N21210 007
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.15MG N21301 009 > DLT > 0.15MG N21210 008
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.175MG N21301 010 > DLT > 0.175MG N21210 009
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.2MG N21301 011 > DLT > 0.2MG N21210 010
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
> ADD > BX 0.3MG N21301 012 > DLT > + 0.3MG N21210 011
> ADD > MAY 25, 2001 > DLT > AUG 21, 2000
UNITHROID
> ADD > BX STEVENS J 0.025MG N21210 001
> ADD > AUG 21, 2000
LINCOMYCIN HYDROCHLORIDE METHSCOPOLAMINE BROMIDE
INJECTABLE; INJECTION TABLET; ORAL
LINCOCIN PAMINE
> DLT > AP + PHARMACIA AND UPJOHN EQ 300MG BASE/ML N50317 001 > DLT > AA + BRADLEY PHARMS 2.5MG N08848 001
> ADD > + EQ 300MG BASE/ML N50317 001 > ADD > + 2.5MG N08848 001
> DLT > LINCOMYCIN HCL
> DLT > AP STERIS EQ 300MG BASE/ML N63180 001
> DLT > APR 16, 1991 METHYLDOPA
> ADD > @ EQ 300MG BASE/ML N63180 001
> ADD > APR 16, 1991 TABLET; ORAL
METHYLDOPA
> DLT > AB LEDERLE 125MG N70070 003
MECLIZINE HYDROCHLORIDE > DLT > OCT 15, 1985
> ADD > @ 125MG N70070 003
TABLET; ORAL > ADD > OCT 15, 1985
MECLIZINE HCL
> DLT > AA CHELSEA LABS 12.5MG N85269 001
> ADD > @ 12.5MG N85269 001 METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
MEPROBAMATE METHYLPHENIDATE HCL
> ADD > AB ABLE 20MG N76032 001
TABLET; ORAL > ADD > MAY 09, 2001
MEPROBAMATE
> DLT > AA HALSEY 400MG N80699 002
> ADD > @ 400MG N80699 002 METHYLPREDNISOLONE ACETATE
INJECTABLE; INJECTION
METHAZOLAMIDE DEPO-MEDROL
> DLT > BP PHARMACIA AND UPJOHN 40MG/ML N11757 001
TABLET; ORAL > ADD > 40MG/ML N11757 001
METHAZOLAMIDE METHYLPREDNISOLONE ACETATE
> DLT > AB APPLIED ANAL 25MG N40011 001 > DLT > BP STERIS 40MG/ML N85600 001
> DLT > JUL 17, 1997 > ADD > @ 40MG/ML N85600 001
> DLT > AB 50MG N40011 002
> DLT > JUL 17, 1997
> ADD > @ 25MG N40011 001 METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
> ADD > JUL 17, 1997
> ADD > @ 50MG N40011 002 > DLT > CREAM; TOPICAL
> ADD > JUL 17, 1997 > DLT > NEO-MEDROL ACETATE
> DLT > + PHARMACIA AND UPJOHN 0.25%;EQ 3.5MG BASE/GM N60611 002
> DLT > 1%;EQ 3.5MG BASE/GM N60611 001
METHSCOPOLAMINE BROMIDE > ADD > @ 0.25%;EQ 3.5MG BASE/GM N60611 002
> ADD > @ 1%;EQ 3.5MG BASE/GM N60611 001
TABLET; ORAL
> DLT > METHSCOPOLAMINE BROMIDE
> DLT > AA PVT FORM 2.5MG N80970 001
> ADD > @ 2.5MG N80970 001
METHYLPREDNISOLONE SODIUM SUCCINATE MEZLOCILLIN SODIUM MONOHYDRATE
INJECTABLE; INJECTION INJECTABLE; INJECTION
METHYLPREDNISOLONE SODIUM SUCCINATE MEZLIN
> DLT > AP GENSIA SICOR PHARMS EQ 500MG BASE/VIAL N81267 001 > DLT > BAYER EQ 2GM BASE/VIAL N62372 001
> DLT > NOV 30, 1992 > DLT > MAY 13, 1982
> DLT > AP EQ 1GM BASE/VIAL N81268 001 > DLT > EQ 3GM BASE/VIAL N62372 002
> DLT > NOV 30, 1992 > DLT > MAY 13, 1982
> ADD > @ EQ 500MG BASE/VIAL N81267 001 > DLT > EQ 4GM BASE/VIAL N62372 003
> ADD > NOV 30, 1992 > DLT > MAY 13, 1982
> ADD > @ EQ 1GM BASE/VIAL N81268 001 > DLT > EQ 20GM BASE/VIAL N62372 004
> ADD > NOV 30, 1992 > DLT > MAR 02, 1988
> ADD > @ EQ 1GM BASE/VIAL N62372 005
> ADD > JAN 13, 1983
METOCLOPRAMIDE HYDROCHLORIDE > ADD > @ EQ 2GM BASE/VIAL N62372 001
> ADD > MAY 13, 1982
INJECTABLE; INJECTION > ADD > @ EQ 3GM BASE/VIAL N62372 002
METOCLOPRAMIDE HCL > ADD > MAY 13, 1982
> DLT > AP ABBOTT EQ 5MG BASE/ML N70506 001 > ADD > @ EQ 4GM BASE/VIAL N62372 003
> DLT > JUN 22, 1989 > ADD > MAY 13, 1982
> ADD > @ EQ 5MG BASE/ML N70506 001 > ADD > @ EQ 20GM BASE/VIAL N62372 004
> ADD > JUN 22, 1989 > ADD > MAR 02, 1988
METRONIDAZOLE MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION INJECTABLE; INJECTION
> DLT > METRO I.V. MIDAZOLAM HCL
> DLT > AP + B BRAUN 500MG/100ML N18674 001 > DLT > AP APOTHECON EQ 1MG BASE/ML N75620 001
> DLT > AUG 31, 1982 > DLT > NOV 01, 2000
> ADD > @ 500MG/100ML N18674 001 > DLT > AP EQ 5MG BASE/ML N75620 002
> ADD > AUG 31, 1982 > DLT > NOV 01, 2000
> DLT > METRONIDAZOLE > DLT > AP EQ 5MG BASE/ML N75641 001
> DLT > AP + ABBOTT 500MG/100ML N18889 001 > DLT > OCT 19, 2000
> DLT > NOV 18, 1983 > ADD > @ EQ 1MG BASE/ML N75620 001
> ADD > @ 500MG/100ML N18889 001 > ADD > NOV 01, 2000
> ADD > NOV 18, 1983 > ADD > @ EQ 5MG BASE/ML N75620 002
> DLT > AP + ELKINS SINN 500MG/100ML N18907 001 > ADD > NOV 01, 2000
> DLT > MAR 30, 1984 > ADD > @ EQ 5MG BASE/ML N75641 001
> ADD > @ 500MG/100ML N18907 001 > ADD > OCT 19, 2000
> ADD > MAR 30, 1984 > DLT > AP ASTRAZENECA EQ 5MG BASE/ML N75263 001
> DLT > JUN 26, 2000
> ADD > @ EQ 5MG BASE/ML N75263 001
MEZLOCILLIN SODIUM MONOHYDRATE > ADD > JUN 26, 2000
INJECTABLE; INJECTION
MEZLIN
> DLT > BAYER EQ 1GM BASE/VIAL N62372 005
> DLT > JAN 13, 1983
MINOCYCLINE HYDROCHLORIDE NAFCILLIN SODIUM
CAPSULE; ORAL INJECTABLE; INJECTION
VECTRIN > DLT > NALLPEN
> DLT > AB MEDICIS EQ 75MG BASE N63067 002 > DLT > AP SMITHKLINE BEECHAM EQ 1GM BASE/VIAL N61999 002
> DLT > SEP 15, 1999 > DLT > AP EQ 2GM BASE/VIAL N61999 003
> DLT > AB EQ 100MG BASE N63067 001 > DLT > AP EQ 10GM BASE/VIAL N61999 004
> DLT > JUL 31, 1990 > ADD > @ EQ 500MG BASE/VIAL N61999 001
> ADD > @ EQ 75MG BASE N63067 002 > ADD > @ EQ 1GM BASE/VIAL N61999 002
> ADD > SEP 15, 1999 > ADD > @ EQ 2GM BASE/VIAL N61999 003
> ADD > @ EQ 100MG BASE N63067 001 > ADD > @ EQ 10GM BASE/VIAL N61999 004
> ADD > JUL 31, 1990 > DLT > UNIPEN
> DLT > AP + WYETH AYERST EQ 500MG BASE/VIAL N50320 001
> DLT > AP EQ 500MG BASE/VIAL N62717 001
NAFCILLIN SODIUM > DLT > DEC 16, 1986
> DLT > AP + EQ 1GM BASE/VIAL N62717 002
INJECTABLE; INJECTION > DLT > DEC 16, 1986
NAFCILLIN SODIUM > DLT > AP + EQ 2GM BASE/VIAL N50320 003
> DLT > AP APOTHECON EQ 500MG BASE/VIAL N61984 001 > DLT > AP EQ 2GM BASE/VIAL N62717 004
> DLT > AP EQ 500MG BASE/VIAL N62527 001 > DLT > DEC 16, 1986
> DLT > AUG 02, 1984 > DLT > AP + EQ 4GM BASE/VIAL N50320 004
> ADD > @ EQ 500MG BASE/VIAL N61984 001 > DLT > AP EQ 10GM BASE/VIAL N50320 005
> ADD > + EQ 500MG BASE/VIAL N62527 001 > ADD > @ EQ 500MG BASE/VIAL N50320 001
> ADD > AUG 02, 1984 > ADD > @ EQ 500MG BASE/VIAL N62717 001
> DLT > AP MARSAM EQ 500MG BASE/VIAL N62844 001 > ADD > DEC 16, 1986
> DLT > OCT 26, 1988 > ADD > @ EQ 1GM BASE/VIAL N62717 002
> DLT > AP EQ 1GM BASE/VIAL N62844 002 > ADD > DEC 16, 1986
> DLT > OCT 26, 1988 > ADD > @ EQ 2GM BASE/VIAL N50320 003
> DLT > AP EQ 2GM BASE/VIAL N62844 004 > ADD > @ EQ 2GM BASE/VIAL N62717 004
> DLT > OCT 26, 1988 > ADD > DEC 16, 1986
> DLT > AP EQ 4GM BASE/VIAL N62844 005 > ADD > @ EQ 4GM BASE/VIAL N50320 004
> DLT > OCT 26, 1988 > ADD > @ EQ 10GM BASE/VIAL N50320 005
> DLT > AP EQ 10GM BASE/VIAL N63008 001 > DLT > UNIPEN IN PLASTIC CONTAINER
> DLT > SEP 29, 1988 > DLT > AP WYETH AYERST EQ 1GM BASE/VIAL N50320 002
> DLT > + EQ 1.5GM BASE/VIAL N62844 003 > ADD > @ EQ 1GM BASE/VIAL N50320 002
> DLT > OCT 26, 1988
> ADD > @ EQ 500MG BASE/VIAL N62844 001
> ADD > OCT 26, 1988 NEOMYCIN SULFATE; POLYMYXIN B SULFATE
> ADD > @ EQ 1GM BASE/VIAL N62844 002
> ADD > OCT 26, 1988 SOLUTION; IRRIGATION
> ADD > @ EQ 1.5GM BASE/VIAL N62844 003 > DLT > NEOMYCIN AND POLYMYXIN B SULFATES
> ADD > OCT 26, 1988 > DLT > AT STERIS EQ 40MG BASE/ML;
> ADD > @ EQ 2GM BASE/VIAL N62844 004 > DLT > 200,000 UNITS/ML N62664 001
> ADD > OCT 26, 1988 > DLT > APR 08, 1986
> ADD > @ EQ 4GM BASE/VIAL N62844 005 > ADD > @ EQ 40MG BASE/ML;
> ADD > OCT 26, 1988 > ADD > 200,000 UNITS/ML N62664 001
> ADD > @ EQ 10GM BASE/VIAL N63008 001 > ADD > APR 08, 1986
> ADD > SEP 29, 1988 NEOSPORIN G.U. IRRIGANT
> DLT > NALLPEN > DLT > AT MONARCH PHARMS EQ 40MG BASE/ML;
> DLT > AP SMITHKLINE BEECHAM EQ 500MG BASE/VIAL N61999 001 > DLT > 200,000 UNITS/ML N60707 001
NEOMYCIN SULFATE; POLYMYXIN B SULFATE NYSTATIN
SOLUTION; IRRIGATION CREAM; TOPICAL
NEOSPORIN G.U. IRRIGANT NYSTATIN
> ADD > MONARCH PHARMS EQ 40MG BASE/ML; > ADD > @ TEVA 100,000 UNITS/GM N61966 001
> ADD > 200,000 UNITS/ML N60707 001
OINTMENT; TOPICAL
> DLT > NILSTAT
NETILMICIN SULFATE > DLT > AT + LEDERLE 100,000 UNITS/GM N61444 001
> ADD > @ 100,000 UNITS/GM N61444 001
> DLT > INJECTABLE; INJECTION NYSTATIN
> DLT > NETROMYCIN > DLT > AT ALTANA 100,000 UNITS/GM N62124 002
> DLT > + SCHERING EQ 100MG BASE/ML N50544 003 > DLT > SEP 23, 1982
> DLT > FEB 28, 1983 > ADD > AT + 100,000 UNITS/GM N62124 002
> ADD > @ EQ 100MG BASE/ML N50544 003 > ADD > SEP 23, 1982
> ADD > FEB 28, 1983
SUSPENSION; ORAL
NYSTATIN
NITROFURAZONE > DLT > AA ROXANE 100,000 UNITS/ML N62832 001
> DLT > DEC 27, 1991
OINTMENT; TOPICAL > ADD > @ 100,000 UNITS/ML N62832 001
NITROFURAZONE > ADD > DEC 27, 1991
> DLT > AT + CLAY PARK 0.2% N84968 001 > DLT > AA TEVA 100,000 UNITS/ML N62670 001
> ADD > @ 0.2% N84968 001 > DLT > JUN 18, 1987
> DLT > AA 100,000 UNITS/ML N62776 001
SOLUTION; TOPICAL > DLT > DEC 17, 1987
NITROFURAZONE > ADD > @ 100,000 UNITS/ML N62670 001
> DLT > AT + CLAY PARK 0.2% N85130 001 > ADD > JUN 18, 1987
> ADD > @ 0.2% N85130 001 > ADD > @ 100,000 UNITS/ML N62776 001
> DLT > AT WENDT 0.2% N87081 001 > ADD > DEC 17, 1987
> ADD > + 0.2% N87081 001
TABLET; ORAL
NYSTATIN
NORETHINDRONE ACETATE > DLT > AA EON 500,000 UNITS N62065 001
> ADD > @ 500,000 UNITS N62065 001
TABLET; ORAL > DLT > AA ROSEMONT 500,000 UNITS N62524 001
NORETHINDRONE ACETATE > DLT > NOV 26, 1985
> ADD > AB BARR 5MG N75951 001 > ADD > @ 500,000 UNITS N62524 001
> ADD > MAY 25, 2001 > ADD > NOV 26, 1985
NYSTATIN NYSTATIN; TRIAMCINOLONE ACETONIDE
CREAM; TOPICAL OINTMENT; TOPICAL
> DLT > NILSTAT > DLT > MYCO-TRIACET II
> DLT > AT LEDERLE 100,000 UNITS/GM N61445 001 > DLT > AT TEVA 100,000 UNITS/GM;0.1% N62045 002
> ADD > @ 100,000 UNITS/GM N61445 001 > DLT > NOV 26, 1985
NYSTATIN > ADD > @ 100,000 UNITS/GM;0.1% N62045 002
> DLT > AT TEVA 100,000 UNITS/GM N61966 001 > ADD > NOV 26, 1985
NYSTATIN; TRIAMCINOLONE ACETONIDE OXYTETRACYCLINE HYDROCHLORIDE
OINTMENT; TOPICAL CAPSULE; ORAL
NYSTATIN AND TRIAMCINOLONE ACETONIDE > ADD > OXYTETRACYCLINE HCL
> DLT > AT CLAY PARK 100,000 UNITS/GM;0.1% N62280 002 > ADD > @ WEST WARD EQ 250MG BASE N60770 001
> DLT OCT 10, 1985 TERRAMYCIN
> ADD > @ 100,000 UNITS/GM;0.1% N62280 002 > DLT > AB + PFIZER EQ 250MG BASE N50286 002
> ADD > OCT 10, 1985 > ADD > + EQ 250MG BASE N50286 002
OXACILLIN SODIUM PENICILLIN G POTASSIUM
INJECTABLE; INJECTION TABLET; ORAL
OXACILLIN SODIUM PENICILLIN G POTASSIUM
> DLT > AP IBI EQ 250MG BASE/VIAL N62798 004 > DLT > AB TEVA 200,000 UNITS N60306 001
> DLT > DEC 11, 1995 > DLT > AB 250,000 UNITS N60306 002
> DLT > AP EQ 500MG BASE/VIAL N62798 005 > DLT > AB 400,000 UNITS N60306 003
> DLT > DEC 11, 1995 > DLT > AB 500,000 UNITS N60306 004
> DLT > AP EQ 1GM BASE/VIAL N62798 001 > ADD > @ 200,000 UNITS N60306 001
> DLT > DEC 11, 1995 > ADD > @ 250,000 UNITS N60306 002
> DLT > AP EQ 2GM BASE/VIAL N62798 002 > ADD > @ 400,000 UNITS N60306 003
> DLT > DEC 11, 1995 > ADD > @ 500,000 UNITS N60306 004
> DLT > EQ 125MG BASE/VIAL N62798 003
> DLT > DEC 11, 1995
> ADD > @ EQ 125MG BASE/VIAL N62798 003 PENICILLIN G PROCAINE
> ADD > DEC 11, 1995
> ADD > @ EQ 250MG BASE/VIAL N62798 004 INJECTABLE; INJECTION
> ADD > DEC 11, 1995 > DLT > PENICILLIN G PROCAINE
> ADD > @ EQ 500MG BASE/VIAL N62798 005 > DLT > PFIZER 300,000 UNITS/VIAL N60099 001
> ADD > DEC 11, 1995 > DLT > + 1,500,000 UNITS/VIAL N60099 002
> ADD > @ EQ 1GM BASE/VIAL N62798 001 > ADD > @ 300,000 UNITS/VIAL N60099 001
> ADD > DEC 11, 1995 > ADD > @ 1,500,000 UNITS/VIAL N60099 002
> ADD > @ EQ 2GM BASE/VIAL N62798 002 > DLT > PFIZERPEN-AS
> ADD > DEC 11, 1995 > DLT > AP + PFIZER 300,000 UNITS/ML N60286 001
> DLT > AP + 600,000 UNITS/ML N60286 002
> ADD > @ 300,000 UNITS/ML N60286 001
OXCARBAZEPINE > ADD > @ 600,000 UNITS/ML N60286 002
WYCILLIN
> ADD > SUSPENSION; ORAL > DLT > AP KING PHARMS 300,000 UNITS/ML N60101 002
> ADD > TRILEPTAL > DLT > AP 600,000 UNITS/ML N60101 001
> ADD > + NOVARTIS 300MG/5ML N21285 001 > ADD > + 300,000 UNITS/ML N60101 002
> ADD > MAY 25, 2001 > ADD > + 600,000 UNITS/ML N60101 001
OXYTETRACYCLINE HYDROCHLORIDE PENICILLIN V POTASSIUM
CAPSULE; ORAL FOR SOLUTION; ORAL
> DLT > OXYTETRACYCLINE HCL PENICILLIN V POTASSIUM
> DLT > AB WEST WARD EQ 250MG BASE N60770 001 > ADD > @ MYLAN EQ 125MG BASE/5ML N61624 002
PENICILLIN V POTASSIUM PHENDIMETRAZINE TARTRATE
FOR SOLUTION; ORAL CAPSULE; ORAL
PENICILLIN V POTASSIUM PHENDIMETRAZINE TARTRATE
> ADD > @ MYLAN EQ 250MG BASE/5ML N61624 001 > DLT > AA EON 35MG N85694 001
> ADD > V-CILLIN K > ADD > @ 35MG N85694 001
> ADD > @ LILLY EQ 125MG BASE/5ML N60004 001
> ADD > @ EQ 250MG BASE/5ML N60004 002 TABLET; ORAL
> ADD > PHENAZINE-35
POWDER FOR RECONSTITUTION; ORAL > ADD > @ ABC HOLDING 35MG N85512 001
PENICILLIN V POTASSIUM > DLT > AA CAMALL 35MG N85512 001
> DLT > AA MYLAN EQ 125MG BASE/5ML N61624 002 PHENDIMETRAZINE TARTRATE
> DLT > AA EQ 250MG BASE/5ML N61624 001 > DLT > AA EON 35MG N85402 001
> DLT > V-CILLIN K > DLT > AA 35MG N85497 001
> DLT > AA LILLY EQ 125MG BASE/5ML N60004 001 > ADD > @ 35MG N85402 001
> DLT > AA EQ 250MG BASE/5ML N60004 002 > ADD > @ 35MG N85497 001
> DLT > AA ROSEMONT 35MG N84399 001
TABLET; ORAL > ADD > @ 35MG N84399 001
PEN-VEE K
> DLT > AB WYETH AYERST EQ 500MG BASE N60006 003
> ADD > AB + EQ 500MG BASE N60006 003 PHENTERMINE HYDROCHLORIDE
PENICILLIN V POTASSIUM
> DLT > AB BIOCHEMIE EQ 500MG BASE N64071 002 CAPSULE; ORAL
> DLT > NOV 30, 1995 PHENTERMINE HCL
> ADD > AB + EQ 500MG BASE N64071 002 > ADD > @ ABC HOLDING 30MG N85411 001
> ADD > NOV 30, 1995 > DLT > AA CAMALL 30MG N85411 001
> DLT > AB MYLAN EQ 250MG BASE N61530 001 > DLT > AA ROSEMONT 30MG N84487 001
> DLT > AB EQ 500MG BASE N61530 002 > DLT > APR 09, 1982
> ADD > @ EQ 250MG BASE N61530 001 > ADD > @ 30MG N84487 001
> ADD > @ EQ 500MG BASE N61530 002 > ADD > APR 09, 1982
> DLT > V-CILLIN K
> DLT > AB LILLY EQ 250MG BASE N60003 002 TABLET; ORAL
> DLT > AB + EQ 500MG BASE N60003 003 PHENTERMINE HCL
> DLT > EQ 125MG BASE N60003 001 > DLT > @ EON 30MG N88605 001
> ADD > @ EQ 125MG BASE N60003 001 > DLT > SEP 28, 1987
> ADD > @ EQ 250MG BASE N60003 002 > ADD > + 30MG N88605 001
> ADD > @ EQ 500MG BASE N60003 003 > ADD > SEP 28, 1987
PERPHENAZINE PIPERAZINE CITRATE
> ADD > CONCENTRATE; ORAL SYRUP; ORAL
> ADD > PERPHENAZINE PIPERAZINE CITRATE
> ADD > + PHARM ASSOC 16MG/5ML N40360 001 > DLT > AA LANNETT EQ 500MG BASE/5ML N80963 001
> ADD > MAY 25, 2001 > ADD > @ EQ 500MG BASE/5ML N80963 001
> DLT > TABLET; ORAL
> DLT > PIPERAZINE CITRATE
> DLT > + IMPAX LABS EQ 250MG BASE N80874 001
PIPERAZINE CITRATE PROMETHAZINE HYDROCHLORIDE
> ADD > TABLET; ORAL SUPPOSITORY; RECTAL
> ADD > PIPERAZINE CITRATE PROMETHACON
> ADD > @ IMPAX LABS EQ 250MG BASE N80874 001 > DLT > BR POLYMEDICA 50MG N84902 001
> ADD > @ 50MG N84902 001
PREDNISOLONE TABLET; ORAL
PHENERGAN
TABLET; ORAL > DLT > BP WYETH AYERST 12.5MG N07935 002
PREDNISOLONE > ADD > 12.5MG N07935 002
> DLT > BX CHELSEA LABS 5MG N85085 002 PROMETHAZINE HCL
> ADD > @ 5MG N85085 002 > DLT > BP LANNETT 12.5MG N80949 001
> DLT > BP 25MG N80949 002
> DLT > BP 50MG N80949 003
PREDNISOLONE SODIUM PHOSPHATE > ADD > @ 12.5MG N80949 001
> ADD > @ 25MG N80949 002
SOLUTION/DROPS; OPHTHALMIC > ADD > @ 50MG N80949 003
PREDNISOLONE SODIUM PHOSPHATE > DLT > BP PVT FORM 25MG N83658 001
> DLT > AT ALCON UNIVERSAL EQ 0.11% PHOSPHATE N81043 001 > ADD > @ 25MG N83658 001
> DLT > OCT 24, 1991
> DLT > AT EQ 0.9% PHOSPHATE N81044 001
> DLT > OCT 24, 1991 PROPOXYPHENE HYDROCHLORIDE
> ADD > @ EQ 0.11% PHOSPHATE N81043 001
> ADD > OCT 24, 1991 CAPSULE; ORAL
> ADD > @ EQ 0.9% PHOSPHATE N81044 001 PROPOXYPHENE HCL
> ADD > OCT 24, 1991 > DLT > AA GENEVA PHARMS 65MG N83125 002
> ADD > @ 65MG N83125 002
> DLT > AA IMPAX LABS 65MG N83317 001
PREDNISONE > ADD > @ 65MG N83317 001
TABLET; ORAL
PREDNISONE PROPRANOLOL HYDROCHLORIDE
> DLT > AB CHELSEA LABS 5MG N85084 002
> ADD > @ 5MG N85084 002 TABLET; ORAL
> DLT > AB GENEVA PHARMS 5MG N80336 002 PROPRANOLOL HCL
> ADD > @ 5MG N80336 002 > DLT > AB LEDERLE 10MG N70125 001
> DLT > BX LANNETT 20MG N84275 001 > DLT > JUL 30, 1985
> ADD > @ 20MG N84275 001 > ADD > @ 10MG N70125 001
> ADD > JUL 30, 1985
> DLT > AB WATSON LABS 20MG N70549 001
PRIMIDONE > DLT > APR 11, 1986
> ADD > @ 20MG N70549 001
TABLET; ORAL > ADD > APR 11, 1986
MYSOLINE
> DLT > ELAN PHARMA 50MG N09170 003
> ADD > AB ELAN PHARMA INTL 50MG N09170 003
PRIMIDONE
> ADD > LANNETT 50MG N84903 002
> ADD > MAY 24, 2001
QUINIDINE SULFATE SULFACETAMIDE SODIUM
TABLET; ORAL OINTMENT; OPHTHALMIC
QUINIDINE SULFATE > DLT > BLEPH-10
> DLT > AB MUTUAL PHARM 300MG N81031 001 > DLT > AT ALLERGAN 10% N84015 001
> DLT > APR 14, 1989 > ADD > @ 10% N84015 001
> ADD > @ 300MG N81031 001 CETAMIDE
> ADD > APR 14, 1989 > DLT > AT ALCON 10% N80021 001
> DLT > AB WEST WARD 200MG N83862 001 > ADD > AT + 10% N80021 001
> ADD > @ 200MG N83862 001 > DLT > SODIUM SULAMYD
> DLT > AT + SCHERING 10% N05963 002
> ADD > @ 10% N05963 002
SILVER SULFADIAZINE
SOLUTION/DROPS; OPHTHALMIC
DRESSING; TOPICAL BLEPH-10
> ADD > SILDAFLO > DLT > AT ALLERGAN 10% N80028 001
> ADD > @ QUESTCOR PHARMS 1% N19608 001 > ADD > AT + 10% N80028 001
> ADD > NOV 30, 1989 BLEPH-30
> DLT > SILDIMAC > DLT > AT ALLERGAN 30% N80028 002
> DLT > @ QUESTCOR PHARM 1% N19608 001 > ADD > AT + 30% N80028 002
> DLT > NOV 30, 1989 > DLT > SODIUM SULAMYD
> DLT > AT + SCHERING 10% N05963 001
> DLT > AT + 30% N05963 003
SODIUM POLYSTYRENE SULFONATE > ADD > @ 10% N05963 001
> ADD > @ 30% N05963 003
SUSPENSION; ORAL, RECTAL
SPS
> DLT > AA CAROLINA MEDCL 15GM/60ML N87859 001 SULFAMETHOXAZOLE
> DLT > DEC 08, 1982
> ADD > AA + 15GM/60ML N87859 001 TABLET; ORAL
> ADD > DEC 08, 1982 GANTANOL
> DLT > AB + ROCHE 500MG N12715 002
> ADD > + 500MG N12715 002
STREPTOMYCIN SULFATE > DLT > SULFAMETHOXAZOLE
> DLT > AB GENEVA PHARMS 500MG N85844 001
INJECTABLE; INJECTION > ADD > @ 500MG N85844 001
> DLT > STREPTOMYCIN SULFATE
> DLT > AP + PFIZER EQ 1GM BASE/VIAL N60076 001
> DLT > + EQ 5GM BASE/VIAL N60076 002 SULFAMETHOXAZOLE; TRIMETHOPRIM
> ADD > @ EQ 1GM BASE/VIAL N60076 001
> ADD > @ EQ 5GM BASE/VIAL N60076 002 TABLET; ORAL
> DLT > AP PHARMA TEK EQ 1GM BASE/VIAL N64210 001 SULFAMETHOXAZOLE AND TRIMETHOPRIM
> DLT > JUN 30, 1998 > DLT > AB TEVA 400MG;80MG N18242 001
> ADD > + EQ 1GM BASE/VIAL N64210 001 > DLT > AB 800MG;160MG N18242 002
> ADD > JUN 30, 1998 > ADD > @ 400MG;80MG N18242 001
> ADD > @ 800MG;160MG N18242 002
TECHNETIUM TC-99M APCITIDE TOBRAMYCIN
INJECTABLE; INJECTION SOLUTION/DROPS; OPHTHALMIC
ACUTECT TOBRAMYCIN
> ADD > BERLEX LABS N/A N20887 001 > ADD > @ ALCON UNIVERSAL 0.3% N63176 001
> ADD > SEP 14, 1998 > ADD > MAY 25, 1994
> DLT > DIATIDE N/A N20887 001
> DLT > SEP 14, 1998
TOBRAMYCIN SULFATE
TETRACYCLINE HYDROCHLORIDE INJECTABLE; INJECTION
TOBRAMYCIN SULFATE
CAPSULE; ORAL > DLT > AP ASTRAZENECA EQ 40MG BASE/ML N63121 001
> DLT > PANMYCIN > DLT > OCT 31, 1994
> DLT > AB PHARMACIA AND UPJOHN 250MG N60347 001 > ADD > @ EQ 40MG BASE/ML N63121 001
> ADD > @ 250MG N60347 001 > ADD > OCT 31, 1994
> DLT > ROBITET > DLT > AP ELKINS SINN EQ 10MG BASE/ML N63128 001
> DLT > AB WYETH AYERST 250MG N61734 001 > DLT > NOV 27, 1991
> DLT > AB 500MG N61734 002 > DLT > AP EQ 40MG BASE/ML N63127 001
> ADD > @ 250MG N61734 001 > DLT > NOV 27, 1991
> ADD > @ 500MG N61734 002 > ADD > @ EQ 10MG BASE/ML N63128 001
TETRACYCLINE HCL > ADD > NOV 27, 1991
> DLT > AB DANBURY PHARMA 250MG N62343 001 > ADD > @ EQ 40MG BASE/ML N63127 001
> DLT > AB 500MG N62343 002 > ADD > NOV 27, 1991
> ADD > @ 250MG N62343 001 > DLT > AP LEDERLE EQ 10MG BASE/ML N63113 001
> ADD > @ 500MG N62343 002 > DLT > APR 26, 1991
> DLT > AB WEST WARD 250MG N60768 001 > ADD > @ EQ 10MG BASE/ML N63113 001
> DLT > AB 500MG N60768 002 > ADD > APR 26, 1991
> ADD > @ 250MG N60768 001
> ADD > @ 500MG N60768 002
TRIAMCINOLONE ACETONIDE
TICARCILLIN DISODIUM CREAM; TOPICAL
TRIAMCINOLONE ACETONIDE
INJECTABLE; INJECTION > DLT > AT TARO 0.025% N40038 001
TICAR > DLT > OCT 26, 1994
> DLT > SMITHKLINE BEECHAM EQ 3GM BASE/VIAL N62690 001 > ADD > @ 0.025% N40038 001
> DLT > DEC 19, 1986 > ADD > OCT 26, 1994
> ADD > @ EQ 3GM BASE/VIAL N62690 001
> ADD > DEC 19, 1986
TRICHLORMETHIAZIDE
TOBRAMYCIN TABLET; ORAL
> DLT > TRICHLOREX
SOLUTION/DROPS; OPHTHALMIC > DLT > BP LANNETT 4MG N83436 001
TOBRAMYCIN > ADD > @ 4MG N83436 001
> DLT > AT ALCON UNIVERSAL 0.3% N63176 001
> DLT > MAY 25, 1994
TRIFLUOPERAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
> DLT > TRIFLUOPERAZINE HCL
> DLT > AA GENEVA PHARMS EQ 10MG BASE/ML N85787 001
> DLT > APR 15, 1982
> ADD > @ EQ 10MG BASE/ML N85787 001
> ADD > APR 15, 1982
VALPROIC ACID
CAPSULE; ORAL
VALPROIC ACID
> DLT > AB PAR PHARM 250MG N70431 001
> DLT > FEB 28, 1986
> ADD > @ 250MG N70431 001
> ADD > FEB 28, 1986
VANCOMYCIN HYDROCHLORIDE
INJECTABLE; INJECTION
VANCOMYCIN HCL
> DLT > AP ELKINS SINN EQ 500MG BASE/VIAL N62879 001
> DLT > AUG 02, 1988
> DLT > AP EQ 1GM BASE/VIAL N62879 002
> DLT > AUG 02, 1988
> ADD > @ EQ 500MG BASE/VIAL N62879 001
> ADD > AUG 02, 1988
> ADD > @ EQ 1GM BASE/VIAL N62879 002
> ADD > AUG 02, 1988
VINBLASTINE SULFATE
INJECTABLE; INJECTION
> DLT > VELBAN
> DLT > AP + LILLY 10MG/VIAL N12665 001
> ADD > @ 10MG/VIAL N12665 001
VINBLASTINE SULFATE
> DLT > AP BEDFORD 10MG/VIAL N89395 001
> DLT > APR 09, 1987
> ADD > AP + 10MG/VIAL N89395 001
> ADD > APR 09, 1987
> DLT > AP FAULDING 10MG/VIAL N89565 001
> DLT > AUG 18, 1987
> ADD > AP 10MG/VIAL N89565 001
> ADD > AUG 18, 1987
FAMOTIDINE
TABLET; ORAL
FAMOTIDINE
> ADD > TEVA 10MG N75312 001
> ADD > MAY 31, 2001
INSULIN PURIFIED PORK
INJECTABLE; INJECTION
REGULAR PURIFIED PORK INSULIN
> DLT > NOVO NORDISK 100 UNITS/ML N18381 001
> ADD > + 100 UNITS/ML N18381 001
INSULIN RECOMBINANT HUMAN
INJECTABLE; INJECTION
NOVOLIN R
> DLT > NOVO NORDISK 100 UNITS/ML N19938 001
> DLT > JUN 25, 1991
> ADD > + 100 UNITS/ML N19938 001
> ADD > JUN 25, 1991
INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT
HUMAN
INJECTABLE; INJECTION
HUMULIN 50/50
> DLT > LILLY 50 UNITS/ML;50 UNITS/ML N20100 001
> DLT > APR 29, 1992
> ADD > + 50 UNITS/ML;50 UNITS/ML N20100 001
> ADD > APR 29, 1992
NOVOLIN 70/30
> DLT > NOVO NORDISK 30 UNITS/ML;70 UNITS/ML N19991 001
> DLT > JUN 25, 1991
> ADD > + 30 UNITS/ML;70 UNITS/ML N19991 001
> ADD > JUN 25, 1991
MICONAZOLE NITRATE
CREAM; TOPICAL, VAGINAL
MONISTAT 3 COMBINATION PACK
> ADD > + PERSONAL PRODS 2%,4% N21261 001
> ADD > FEB 02, 2001
Last update: July 15, 2005 |
|